Background: Activating transcription factor 2 (ATF2) is a member of the leucine zipper
| INTRODUCTION
Opioid analgesics are widely used for the treatment of moderateto-severe pain during the perioperative period and in palliative care, although analgesic efficacy is well known to vary widely among individuals. Both environmental and genetic factors are involved in individual differences in opioid sensitivity. 1 The influence of environmental factors, such as surgical factors, preoperative pain factors, demographics, and psychological factors, can be controlled by the study design, but the influence of genetic factors is not as easily controlled. 2 To date, associations between several gene polymorphisms and fentanyl efficacy were reported. 3, 4 The present study explored possible associations between the analgesic efficacy of fentanyl and single nucleotide polymorphisms (SNPs) near the activating transcription factor 2 (ATF2) gene region. 5 Our recent study found that the rs2952768 SNP, which is located close to the CREB1 gene, was associated with CREB1 mRNA expression and opioid sensitivity. 6 The CREB1 gene is located relatively close to the ATF2 gene region (2q31-33). Activating transcription factor 2 (ATF2; previously called CREB2) is categorized as a member of the cyclic adenosine monophosphate responsive element-binding protein (CREB) family. Similar to CREB1, ATF2 gene encodes an activating transcription factor that is a CRE-binding transcription factor. ATF2 is a member of the leucine zipper family of DNA binding proteins and is widely distributed in tissues, including the liver, lung, spleen, and kidney. 7 ATF2 is also expressed in the cytoplasm at the outer mitochondrial membrane. 7 Although ATF2 functions differently from CREB1 in the signaling pathway, Crohn's disease was shown to be associated with CREB1 and ATF2 through deleted in malignant brain tumor 1 (DMBT1) gene expression. 8 Moreover, the interplay between CREB1
and ATF2 was related to the progression of prostate cancer. 9 Since a 1996 study reported that ATF2-deficient mice were chondrodysplasic and presented neurological abnormalities, 10 ATF2 has been more widely investigated. Several recent studies demonstrated that this protein is involved in mechanisms that are related to pain and regulated by p38 mitogen-activated protein kinase in inflammation. 5 However, unclear is whether polymorphisms of the ATF2 gene, which encodes the human ATF2 protein, influence pain or analgesic sensitivity.
| MATERIALS AND METHODS

| Patients
The protocol for this research project was approved by the Ethics
Committees of Tokyo Dental College and the Tokyo Metropolitan
Institute of Medical Science (approval no. 086 and 15-6, respectively) and conformed with the provisions of the Declaration of Helsinki.
Written informed consent was obtained from all of the patients and from the parents if the patient was younger than 20 years old.
Enrolled in the study were 355 healthy patients (American Society of Anesthesiologists Physical Status I, 15-52 years old, 126 males and 229 females) who were scheduled to undergo orthognathic surgery (ie, bilateral mandibular sagittal split ramus osteotomy) for mandibular prognathism at Tokyo Dental College Suidobashi Hospital. Patients were excluded preoperatively if they had a history of acute or chronic kidney injury, drug abuse, or chronic pain or were unable to use the intravenous patient-controlled analgesia (IV-PCA) device.
| Cold pressor-induced pain test
The temperature in the operating room was maintained at 26°C.
Crushed ice cubes and cold water were blended 15 minutes before testing in a 5-L isolated tank, and the mixture was stirred immediately before the test to ensure uniform temperature distribution (0°C)
within the tank. The dominant hand was immersed up to the hand and wrist because the nondominant hand is where the venous line was 
| Anesthesia and surgery
The patients were orally premedicated with 5 mg diazepam and 150 mg famotidine 90 minutes before the induction of anesthesia.
General anesthesia was induced with propofol at a target blood concentration of 4-6 lg/mL using a target-controlled infusion (TCI) pump (TE-317, Terumo, Tokyo, Japan). Vecuronium (0.1 mg/kg) was administered to facilitate nasotracheal intubation (Portex; inner diameter, 6.5-8.0 mm; Smiths Medical Japan, Tokyo, Japan) and maintained at 0.08 mg/kg/h during surgery. Whenever systolic blood pressure or heart rate increased more than 20% over baseline during surgery, fentanyl was intravenously administered at 1 lg/kg.
The lungs were ventilated with oxygen-enriched air. All of the patients received local anesthesia at the surgical sites with 8 mL of 2% lidocaine that contained 12.5 lg/mL epinephrine.
| Postoperative pain management
At the end of surgery, 50 mg rectal diclofenac sodium and 8 mg intravenous dexamethasone were administered to prevent postoperative orofacial edema/swelling. After emergence from anesthesia and tracheal extubation, 1.25 mg droperidol was intravenously administered to prevent nausea/vomiting, and IV-PCA with 20 lg/mL fentanyl commenced using a CADD-Legacy PCA pump (Smiths Medical Japan, Tokyo, Japan). Droperidol (0.1 mg/mL) was co-administered with AOKI ET AL.
| 87 fentanyl to prevent nausea/vomiting because of a high incidence (up to 30%) of nausea/vomiting with PCA fentanyl in young females. A bolus dose of fentanyl of 20 lg on demand and a lockout time of 10 minutes were set. Continuous background infusion was not employed. Patient-controlled analgesia was continued for 24 hours postoperatively. In the case of refractory adverse effects or inadequate analgesia, PCA with fentanyl was discontinued, and 50 mg rectal diclofenac sodium was prescribed as a rescue analgesic as required.
Postoperative fentanyl use (lg/kg) for 24 h, standardized by body weight, was calculated based on PCA pump records. The intensity of spontaneous pain was assessed 3 and 24 hours postoperatively using a 100-mm visual analog scale (VAS), with 0 mm indicating no pain and 100 mm indicating the worst pain imaginable.
| Genotyping and linkage disequilibrium analysis
After genomic DNA was extracted from whole-blood samples using standard procedures, whole-genome genotyping was performed using the Infinium assay II with an iScan system (Illumina, San Diego, CA, USA) according to the manufacturer's instructions. The genotype data were evaluated as detailed in our previous report. 6 Briefly, the data for the whole-genome genotyped samples were analyzed using BeadStu- only the markers that were common to all of the BeadChips were included in the analysis, and the others were automatically excluded).
In the data-cleaning process, the samples with a genotype call rate of 
Haploview and has been detailed in a previous report. 6 
| Statistical analysis
Prior to the analyses, postoperative fentanyl use for 24 hours was natural-log-transformed for approximation to the normal distribution as described in our previous study. 6 Additionally, the quantitative values of the analgesic effect of fentanyl in the preoperative cold pressor-induced pain test, evaluated as the difference between PPLpre and PPL-post (in seconds), and 3 and 24 hours postoperative VASs were similarly natural-log-transformed.
Associations between the Tag SNPs and the natural-log-transformed clinical data were analyzed using linear regression. All of the statistical tests were performed using SPSS 19.0 software (SPSS, Chicago, IL, USA). The threshold for statistical significance was P < .05. The correction for multiple testing was performed using
Bonferroni adjustments. The genotype distributions were checked using the chi-square test, and the absence of significant deviation from the theoretical distribution that is expected from Hardy-Weinberg equilibrium was confirmed.
| RESULTS
In the present study, 33 SNPs were selected, and a total of 2 LD blocks with 6 Tag SNPs (rs1153702, rs7583431, rs2302663, rs3845744, rs268214, and rs1982235) were observed in the region within and around the ATF2 gene (Figures 1 and 2 ). We further analyzed associations between these Tag SNPs and the clinical data (Table S1 ). After correcting for multiple testing using Bonferroni adjustments, an increase in the analgesic effect of fentanyl in the cold pressor-induced pain test was significantly associated with a greater copy number of the A allele of the rs7583431 SNP (linear regression; b = À0.184, P = .001; Table S2 The genotype distribution of the rs7583431 SNP was checked using the chi-square test, and the absence of significant deviation from the theoretical distribution that is expected from Hardy-Weinberg equilibrium was confirmed (v 2 = 2.3324, P = .127).
| DISCUSSION
Initially, genotype data were analyzed for SNPs within and around the ATF2 gene region. For the 33 SNPs that were selected in this region, LD analysis was conducted. A total of 2 LD blocks were observed, and 6 Tag SNPs were selected. Among these, the rs7583431 SNP (1 of the 6 Tag SNPs) was associated with the analgesic effect of fentanyl in the preoperative cold pressor-induced pain test.
ATF proteins are well known as procarcinogenic factors in tumors of the prostate, breast, liver, and lung. 7 Some reports indicate the involvement of CREB and the cAMP pathway in the analgesic and rewarding effects of opioids. [15] [16] [17] [18] Moreover, our previous study reported that higher mRNA expression levels of the CREB1 gene in subjects with the C/C genotype of the rs2952768 SNP, 
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